The Form 4 filing, a report of insider stock trades, was submitted on November 10, 2026. The earliest purchase date was November 6, 2026, and the latest was November 9, 2026.
The report identifies Cristiano Amoruso as a director of Magnachip Semiconductor Corp (MX). The company is listed in the technology sector and semiconductor industry.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-06 |
| Date of Latest Transaction | 2026-11-09 |
| Buy/Sell | buy |
| Transaction Count | 2 |
| Shares Transacted | 568,009 |
| Price | $2.41 |
| Total Transaction Value | $1,371,146.03 |
| Insider | |
| Ticker Symbol | MX |
| Company | MAGNACHIP SEMICONDUCTOR Corp |
| Insider Name | Amoruso Cristiano |
| Insider Title | Director |
| Sector - Industry | Technology - Semiconductors |
| Holdings | |
| Total Shares Owned After Transaction | 3,262,536 |
| Position Size Change | 17.41% |
| Filing | |
| Filing Date | 2026-11-10 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
These were share purchases, reported under transaction code P. The two purchase transactions are covered by the same filing.
What was the average price of the transaction?
The average price was $2.41 per share, rounded to the nearest cent. This average covers both purchases. Separate prices for each transaction are not available here.
How did this transaction affect the insider's holdings?
Cristiano Amoruso bought 568,009 shares and reported owning 3,262,536 shares afterward. The shares he bought made up 17.41% of the shares he reported owning after the purchases.
What's the total transaction value?
The two purchases had a total value of $1,371,146.03, rounded to the nearest cent. This total covers both transactions.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement for these purchases. Filing footnote text is not available here, so any further terms or explanations remain unknown.
For research purposes only; not investment advice.